Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.

Andreotti F, Testa L, Biondi-Zoccai GG, Crea F.

Eur Heart J. 2006 Mar;27(5):519-26. Epub 2005 Sep 5. Review.

PMID:
16143706
2.

Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

Arjomand H, Cohen M, Ezekowitz MD.

J Invasive Cardiol. 2004 May;16(5):271-8. Review.

PMID:
15152137
3.

Oral anticoagulants in patients with coronary artery disease.

Anand SS, Yusuf S.

J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):62S-69S. Review.

PMID:
12644343
4.
5.

The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction.

Jafri SM, Zarowitz B, Goldstein S, Lesch M.

Prog Cardiovasc Dis. 1993 Jul-Aug;36(1):75-83. Review.

PMID:
8321905
6.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Epub 2008 Feb 11. Review.

PMID:
18359315
7.

Evidence-based medical therapy of patients with acute coronary syndromes.

Ramanath VS, Eagle KA.

Am J Cardiovasc Drugs. 2007;7(2):95-116. Review.

PMID:
17503881
8.

Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

Hermosillo AJ, Spinler SA.

Ann Pharmacother. 2008 Jun;42(6):790-805. doi: 10.1345/aph.1K591. Epub 2008 May 13. Review. Erratum in: Ann Pharmacother. 2008 Oct;42(10):1521.

PMID:
18477734
9.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
10.

Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.

Redman AR, Allen LC.

Curr Atheroscler Rep. 2002 Jul;4(4):319-25. Review.

PMID:
12052284
11.

Oral anticoagulant treatment with and without aspirin.

Altman R, Rouvier J, Gurfinkel E.

Thromb Haemost. 1995 Jul;74(1):506-10. Review.

PMID:
8578514
12.

Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction.

Haq SA, Heitner JF, Sacchi TJ, Brener SJ.

Am J Med. 2010 Mar;123(3):250-8. doi: 10.1016/j.amjmed.2009.08.016. Review.

PMID:
20193834
13.

Warfarin for ischemic heart disease.

Verheugt FW.

Cardiol Rev. 2001 Nov-Dec;9(6):325-8. Review.

PMID:
11696261
14.

[Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].

Reikvam A, Madsen S, Landmark K.

Tidsskr Nor Laegeforen. 2003 Jun 26;123(13-14):1838-40. Review. Norwegian.

PMID:
12830258
15.

[Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].

Di Pasquale G, Ottani F, Ceré E, Biancoli S, Sassone B, Lombardi A.

Recenti Prog Med. 1998 Oct;89(10):514-9. Review. Italian.

PMID:
9842255
16.

Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.

Andersen LV, Vestergaard P, Deichgraeber P, Lindholt JS, Mortensen LS, Frost L.

Heart. 2008 Dec;94(12):1607-13. doi: 10.1136/hrt.2007.135657. Epub 2008 Jan 20. Review.

PMID:
18208828
17.

[Antithrombotic treatment following acute ischemic heart disease: acetylsalicylic acid and (or) oral anticoagulants?; ASPECT-II, a new study].

van Es RF, Grobbee DE, Deckers JW, Bak AA, Verheugt FW, Jonker JJ.

Ned Tijdschr Geneeskd. 1997 Nov 1;141(44):2129-31. Review. Dutch.

PMID:
9550777
18.

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM; American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology.

Circulation. 2007 May 15;115(19):2549-69. Review.

19.

Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.

Kumar G, Goyal MK.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1279-87. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.015. Epub 2012 Nov 20. Review.

PMID:
23182364
20.

Optimising stroke prevention in non-valvular atrial fibrillation.

Ederhy S, Cohen A.

Expert Opin Pharmacother. 2006 Oct;7(15):2079-94. Review.

PMID:
17020434

Supplemental Content

Support Center